此前,在今年2月初四环医药已经在市场公告盈警,而近日其年度成绩单正式出炉,至此财报靴子落地。01财报亮点透视,"双引擎"驱动价值重估当下四环医药无疑是站在了"医美爆发"和"创新药拐点"两个黄金赛道的交汇点。梳理公司这份年度财报的亮点如下:1、医美业务增长强劲。医美业务实现收入7.44亿元,同比增长65.4%。新产品持续获批并贡献收入,推动医美业务利润率进一步提升。2、创新药业务快速发展。创新药及其...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.